内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

甲状腺功能减退症基层诊疗指南（实践版·2019）

2019-11-30 中华医学会 中华全科医师杂志.2019,18(11):1029-1033.

甲状腺功能减退症基层诊疗

甲状腺功能减退症(hypothyroidism)简称甲减。我国甲减的患病率为17．8％，其中亚临床甲减患病率为16．7％，临床甲减患病率为1．1％‘1I。女性高于男性，随年龄增长患病率升高。

中文标题：

甲状腺功能减退症基层诊疗指南（实践版·2019）

发布机构：

中华医学会

发布日期：

2019-11-30

简要介绍：

甲状腺功能减退症(hypothyroidism)简称甲减。我国甲减的患病率为17．8％，其中亚临床甲减患病率为16．7％，临床甲减患病率为1．1％‘1I。女性高于男性，随年龄增长患病率升高。

 

拓展指南：与甲状腺相关指南：

下载附件：
点击下载

(因为版权问题，不支持下载)

评论区 (40)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1206708, encodeId=18251206e0834, content=怎样下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b45430054, createdName=ms1000001370311315, createdTime=Mon Mar 28 21:07:46 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065070, encodeId=bb6f10650e005, content=下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9b5541894, createdName=ms9000000199271683, createdTime=Fri Oct 29 19:28:01 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061162, encodeId=9f3510611621c, content=左甲状腺素的副作用不容忽视, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8b1521315, createdName=lljjcc7312, createdTime=Sun Oct 17 06:36:50 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053570, encodeId=415610535e019, content=目前甲状腺功能减退症患者呈增多趋势，应进一步熟悉诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67494040871, createdName=13aa3ddam23暂无昵称, createdTime=Tue Sep 21 20:58:55 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015986, encodeId=19f5101598662, content=下载了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62245484382, createdName=ms5000000334033928, createdTime=Thu Sep 09 10:03:03 CST 2021, time=2021-09-09, status=1, ipAttribution=)]
    2022-03-28 ms1000001370311315

    怎样下载

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1206708, encodeId=18251206e0834, content=怎样下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b45430054, createdName=ms1000001370311315, createdTime=Mon Mar 28 21:07:46 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065070, encodeId=bb6f10650e005, content=下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9b5541894, createdName=ms9000000199271683, createdTime=Fri Oct 29 19:28:01 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061162, encodeId=9f3510611621c, content=左甲状腺素的副作用不容忽视, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8b1521315, createdName=lljjcc7312, createdTime=Sun Oct 17 06:36:50 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053570, encodeId=415610535e019, content=目前甲状腺功能减退症患者呈增多趋势，应进一步熟悉诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67494040871, createdName=13aa3ddam23暂无昵称, createdTime=Tue Sep 21 20:58:55 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015986, encodeId=19f5101598662, content=下载了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62245484382, createdName=ms5000000334033928, createdTime=Thu Sep 09 10:03:03 CST 2021, time=2021-09-09, status=1, ipAttribution=)]
    2021-10-29 ms9000000199271683

    下载

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1206708, encodeId=18251206e0834, content=怎样下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b45430054, createdName=ms1000001370311315, createdTime=Mon Mar 28 21:07:46 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065070, encodeId=bb6f10650e005, content=下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9b5541894, createdName=ms9000000199271683, createdTime=Fri Oct 29 19:28:01 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061162, encodeId=9f3510611621c, content=左甲状腺素的副作用不容忽视, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8b1521315, createdName=lljjcc7312, createdTime=Sun Oct 17 06:36:50 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053570, encodeId=415610535e019, content=目前甲状腺功能减退症患者呈增多趋势，应进一步熟悉诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67494040871, createdName=13aa3ddam23暂无昵称, createdTime=Tue Sep 21 20:58:55 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015986, encodeId=19f5101598662, content=下载了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62245484382, createdName=ms5000000334033928, createdTime=Thu Sep 09 10:03:03 CST 2021, time=2021-09-09, status=1, ipAttribution=)]
    2021-10-17 lljjcc7312

    左甲状腺素的副作用不容忽视

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1206708, encodeId=18251206e0834, content=怎样下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b45430054, createdName=ms1000001370311315, createdTime=Mon Mar 28 21:07:46 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065070, encodeId=bb6f10650e005, content=下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9b5541894, createdName=ms9000000199271683, createdTime=Fri Oct 29 19:28:01 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061162, encodeId=9f3510611621c, content=左甲状腺素的副作用不容忽视, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8b1521315, createdName=lljjcc7312, createdTime=Sun Oct 17 06:36:50 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053570, encodeId=415610535e019, content=目前甲状腺功能减退症患者呈增多趋势，应进一步熟悉诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67494040871, createdName=13aa3ddam23暂无昵称, createdTime=Tue Sep 21 20:58:55 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015986, encodeId=19f5101598662, content=下载了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62245484382, createdName=ms5000000334033928, createdTime=Thu Sep 09 10:03:03 CST 2021, time=2021-09-09, status=1, ipAttribution=)]
    2021-09-21 13aa3ddam23暂无昵称

    目前甲状腺功能减退症患者呈增多趋势，应进一步熟悉诊疗指南

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1206708, encodeId=18251206e0834, content=怎样下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b45430054, createdName=ms1000001370311315, createdTime=Mon Mar 28 21:07:46 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065070, encodeId=bb6f10650e005, content=下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9b5541894, createdName=ms9000000199271683, createdTime=Fri Oct 29 19:28:01 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061162, encodeId=9f3510611621c, content=左甲状腺素的副作用不容忽视, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f8b1521315, createdName=lljjcc7312, createdTime=Sun Oct 17 06:36:50 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053570, encodeId=415610535e019, content=目前甲状腺功能减退症患者呈增多趋势，应进一步熟悉诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67494040871, createdName=13aa3ddam23暂无昵称, createdTime=Tue Sep 21 20:58:55 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015986, encodeId=19f5101598662, content=下载了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62245484382, createdName=ms5000000334033928, createdTime=Thu Sep 09 10:03:03 CST 2021, time=2021-09-09, status=1, ipAttribution=)]
    2021-09-09 ms5000000334033928

    下载了

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2016 SIE/AIT建议：应用左旋甲状腺素和左旋三碘甲状腺氨酸治疗甲状腺功能减退症

意大利内分泌学会(SIE,Italian Society of Endocrinology) · 2016-07-29

2012ATA/AACE指南： 成人甲状腺功能减退症新版临床实践指南

美国甲状腺协会(ATA,American Thyroid Association) · 2013-03-10